Respirion

Respirion is a clinical-stage biotech company developing a novel treatment for cystic fibrosis lung infections by reducing the bacterial burden to improve lung function.

Existing therapies often leave persistent infections untreated. Respirion aims to fill this gap with a more targeted, effective approach to chronic cystic fibrosis lung infections.